Federated Hermes’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-27,487
Closed -$209K – 2350
2021
Q3
$209K Sell
27,487
-47,513
-63% -$401K ﹤0.01% 1651
2021
Q2
$498K Sell
75,000
-499,756
-87% -$3.15M ﹤0.01% 1512
2021
Q1
$6.96M Buy
+574,756
New +$11.4M 0.01% 762

Other funds holding LHDX

Federated Hermes's LHDX Position: Q4 2021 in Review

Federated Hermes sold out of Lucira Health, Inc. Common Stock (LHDX) in Q4 2021, closing a stake of 27,487 shares — an estimated $209K sold.

Federated Hermes first reported a position in LHDX in Q1 2021 and held it in 3 quarters. The position peaked at $6.96M in Q1 2021. 46 funds tracked by Wall St. Rank hold LHDX as of Q4 2021.

  • Federated Hermes reported no remaining Lucira Health, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Federated Hermes sold 27,487 Lucira Health, Inc. Common Stock shares in Q4 2021, an estimated $209K.
  • Federated Hermes first reported a position in Lucira Health, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • Federated Hermes's Lucira Health, Inc. Common Stock position peaked at $6.96M in Q1 2021.
  • 46 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q4 2021.

Based on Federated Hermes's 13F filing for Q4 2021, filed 14 Feb 2022.